Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention

Journal of the American College of Cardiology

Volumn 65, Issue 14, 2015, Pages 1411-1420

  Kazi, Dhruv S ^a,b   Leong, Thomas K ^c   Chang, Tara I ^d   Solomon, Matthew D ^c,d   Hlatky, Mark A ^d,e   Go, Alan S ^a,c,e  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

antiplatelet agents; health outcomes; health services research; hemorrhage; personalized medicine

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SPONTANEOUS BLEEDING; LONGITUDINAL STUDY; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES;

EID: 84926318077     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.01.047     Document Type: Article

References (51)

1. M. Moscucci, K.A. Fox, and C.P. Cannon Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
2. S.K. Mehta, A.D. Frutkin, J.B. Lindsey for the National Cardiovascular Data Registry Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry Circ Cardiovasc Interv 2 2009 222 229
3. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
4. A.K. Chhatriwalla, A.P. Amin, K.F. Kennedy for the National Cardiovascular Data Registry Association between bleeding events and in-hospital mortality after percutaneous coronary intervention JAMA 309 2013 1022 1029
5. S.R. Mehta, S. Yusuf, R.J. Peters for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
6. C.P. Cannon, R.A. Harrington, S. James for the PLATelet Inhibition and patient Outcomes Investigators Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 2010 283 293
7. J.B. Lindsey, S.P. Marso, M. Pencina for the EVENT Registry Investigators Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry J Am Coll Cardiol Intv 2 2009 1074 1082
8. R. Mehran, S.J. Pocock, and G.W. Stone Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
9. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
10. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
11. J.W. Eikelboom, S.R. Mehta, and S.S. Anand Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
12. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368
13. A.M. Lincoff, J.A. Bittl, R.A. Harrington for the REPLACE-2 Investigators Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
14. T.B. Newman, and A.N. Brown Use of commercial record linkage software and vital statistics to identify patient deaths J Am Med Inform Assoc 4 1997 233 237
15. M.G. Arellano, G.R. Petersen, and D.B. Petitti The California Automated Mortality Linkage System (CAMLIS) Am J Public Health 74 1984 1324 1330
16. R.W. Yeh, S. Sidney, and M. Chandra Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
17. A.S. Go, E.M. Hylek, and Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
18. D.E. Singer, Y. Chang, and M.C. Fang Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study Circ Cardiovasc Qual Outcomes 2 2009 297 304
19. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
20. P.S. Romano, and D.H. Mark Bias in the coding of hospital discharge data and its implications for quality assessment Med Care 32 1994 81 90
21. R.M. Carnahan, R.A. Herman, and K.G. Moores A systematic review of validated methods for identifying transfusion-related sepsis using administrative and claims data Pharmacoepidemiol Drug Saf 21 2012 222 229
22. A.S. Go, G.M. Chertow, and D. Fan Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
23. A.S. Go, W.Y. Lee, and J. Yang Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111
24. J.V. Selby, G.T. Ray, and D. Zhang Excess costs of medical care for patients with diabetes in a managed care population Diabetes Care 20 1997 1396 1402
25. A.S. Levey, J. Coresh, T. Greene for the Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
26. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 2002 S1 S266
27. A.S. Go, J. Yang, and L.M. Ackerson Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study Circulation 113 2006 2713 2723
28. A.S. Go, J. Yang, and J.H. Gurwitz Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice Arch Intern Med 168 2008 2415 2421
29. F.A. Masoudi, A. Ponirakis, and R.W. Yeh Cardiovascular care facts: a report from the national cardiovascular data registry: 2011 J Am Coll Cardiol 62 2013 1931 1947
30. J.P. Bassand Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm Eur Heart J 28 2007 1273 1274
31. J.P. Vavalle, and S.V. Rao The association between the transradial approach for percutaneous coronary interventions and bleeding J Invasive Cardiol 21 8 Suppl A 2009 21A 24A
32. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
33. J.P. Vavalle, and S.V. Rao Impact of bleeding complications on outcomes after percutaneous coronary interventions Interv Cardiol 1 2009 51 62
34. A. Gutierrez, and S.V. Rao Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes Cleve Clin J Med 77 2010 369 379
35. A. Gehi, J. Ix, and M. Shlipak Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul study) Am J Cardiol 95 2005 1474 1477
36. G. Olivetti, F. Quaini, and C. Lagrasta Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats Am J Pathol 141 1992 227 239
37. D. Aronson, M. Suleiman, and Y. Agmon Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction Eur Heart J 28 2007 1289 1296
38. A.J. Chase, E.B. Fretz, and W.P. Warburton Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) Heart 94 2008 1019 1025
39. G.W. Stone, B. Witzenbichler, G. Guagliumi for the HORIZONS-AMI Trial Investigators Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
40. S.V. Rao, C.N. Hess, and B. Barham A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial J Am Coll Cardiol Intv 7 2014 857 867
41. S.S. Jolly, S. Yusuf, J. Cairns for the RIVAL trial group Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
42. G.W. Stone, B.T. McLaurin, D.A. Cox for the ACUITY Investigators Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
43. S.V. Rao Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies Am J Cardiol 104 2009 60C 63C
44. S.P. Marso, A.P. Amin, J.A. House for the National Cardiovascular Data Registry Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention JAMA 303 2010 2156 2164
45. N.S. Abraham, M.A. Hlatky, and E.M. Antman ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 56 2010 2051 2066
46. F.H. Ng, K.F. Lam, and S.Y. Wong Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy Digestion 77 2008 173 177
47. S.D. Wiviott, E. Braunwald, C.H. McCabe for the TRITON-TIMI 38 Investigators Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
48. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
49. D.S. Kazi, A.M. Garber, and R.U. Shah Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome Ann Intern Med 160 2014 221 232
50. S.D. Wiviott, E. Braunwald, C.H. McCabe for the TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
51. L. Wallentin, R.C. Becker, A. Budaj for the PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057